Is Ozempic covered by insurance? What to expect in 2026 and how to lower your cost

Most insurance plans cover Ozempic when you have a documented type 2 diabetes diagnosis, but coverage now almost always runs through prior authorization — paperwork your prescriber sends to the insurer before you can fill the prescription. Coverage for weight loss alone is generally not available because Ozempic isn't FDA-approved for that indication; the related drug Wegovy is. Without insurance, the cash price is around $968 a month.^2,3

Is Ozempic actually covered by my insurance?

Coverage depends on three things: your diagnosis, your plan's formulary, and whether prior authorization clears.

• Type 2 diabetes: Most commercial plans, Medicare Part D, and many Medicaid programs cover Ozempic for type 2 diabetes. Coverage for injectable semaglutide has stayed above 90% across Medicare Part D plans since 2021.²
• Weight loss only: Off-label coverage for weight loss without diabetes is uncommon. Plans that do cover GLP-1s for weight loss usually do so under a separate anti-obesity drug rider — and they typically cover Wegovy, not Ozempic.³
• Cardiovascular risk reduction: Ozempic also has an FDA indication for reducing major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. Some plans approve PA on that basis.³

Why is prior authorization so common now?

PA requirements for GLP-1 drugs jumped from below 15% in the third quarter of 2023 to more than 80% by late 2024.² Insurers tightened controls because GLP-1 use surged and plans wanted to confirm prescriptions match FDA indications.

What plans typically require for approval:

• A documented type 2 diabetes diagnosis (an A1C of 6.5% or higher, or two fasting glucose readings of 126 mg/dL or higher)
• A trial of first-line therapy — usually metformin — unless medically contraindicated
• Ongoing monitoring (regular A1C checks, follow-up visits)
• For the cardiovascular indication: documented atherosclerotic cardiovascular disease

How much does Ozempic cost in 2026?

With insurance

If your plan covers Ozempic and PA clears, you'll pay your standard tier copay — often $25 to $100 per month for preferred-tier coverage and $100 to $400+ for non-preferred tier. Some high-deductible plans require you to meet the deductible first, which can mean paying full price for the first month or two of the year.

Without insurance

The U.S. list price is approximately $968 per month before any discounts. Ways to lower that:

• Manufacturer savings cards. Novo Nordisk's Ozempic savings card cuts the price for commercially insured patients with diabetes.
• NovoCare direct-pay. Novo Nordisk offers a self-pay channel for eligible patients without insurance coverage.
• Pharmacy discount cards. GoodRx, Cost Plus Drugs, and similar programs sometimes show meaningful discounts.
• 90-day supply through mail order. Per-month cost often drops when filled in 90-day quantities.
• Patient assistance programs. Novo Nordisk's PAP provides free medication for eligible low-income patients who meet criteria.

Medicare coverage in 2026: What's changing

Medicare Part D continues to cover Ozempic for type 2 diabetes. In addition, CMS launched the Medicare GLP-1 Bridge demonstration on July 1, 2026, for eligible Part D beneficiaries. To qualify, you must be 18 or older with a BMI of 27 or higher plus at least one of:¹

• Prediabetes
• Previous myocardial infarction
• Previous stroke
• Symptomatic peripheral artery disease

The Bridge runs through December 31, 2027. Separately, semaglutide products (Ozempic, Wegovy, Rybelsus) were selected for Medicare drug price negotiation with the negotiated price taking effect in 2027.¹

What about Medicaid?

State Medicaid programs vary. Most cover Ozempic for type 2 diabetes with prior authorization. Coverage for GLP-1s for weight loss is patchwork — some states are expanding access, others have explicit exclusions. Check your state Medicaid formulary or contact the plan.

If my insurance denies coverage, what are my options?

1. Appeal the denial. Most denials are reversed when the chart clearly documents the FDA-approved indication. Your prescriber files the appeal.
2. Switch GLP-1s. Other GLP-1 receptor agonists (Trulicity, Mounjaro, Victoza) may be on your formulary at a lower tier.
3. Use a formulary alternative. SGLT2 inhibitors (Jardiance, Farxiga) are sometimes preferred for type 2 diabetes with cardiovascular indications.
4. Apply for patient assistance. Novo Nordisk's PAP offers free medication for qualifying low-income patients.
5. Use the manufacturer's direct-pay program. NovoCare's self-pay channel is available for eligible self-paying patients.

Next steps

If you're starting GLP-1 therapy or running into PA hurdles, an urgent care or primary care visit can help. A clinician can confirm your diagnosis, document the criteria your plan requires, and submit the PA paperwork — often the difference between approval and denial. You can find same-day primary care and urgent care visits on Solv when you need a quick clinical sign-off or refill.